Prospective Observational Single Arm Open-Label Multicenter Study to Assess the Safety, Tolerability and Efficacy of ellaOne (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Adult Women.
Phase of Trial: Phase IV
Latest Information Update: 31 May 2014
At a glance
- Drugs Ulipristal (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Sponsors HRA Pharma
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 22 Apr 2010 New trial record